Medical Properties Trust (NYSE:MPW) Rating Lowered to Hold at Zacks Investment Research

Thursday, April 8, 2021 | MarketBeat

Medical Properties Trust (NYSE:MPW) was downgraded by Zacks Investment Research from a "buy" rating to a "hold" rating in a research note issued to investors on Thursday, Zacks.com reports.

According to Zacks, "Medical Properties Trust, Inc. is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model allows hospitals and other healthcare facilities to unlock the value of their underlying real estate in order to fund facility improvements, technology upgrades, staff additions and new construction. Facilities include acute care hospitals, inpatient rehabilitation hospitals, long-term acute care hospitals, and other medical and surgical facilities. "

Several other research firms have also recently weighed in on MPW. KeyCorp raised their target price on shares of Medical Properties Trust from $22.00 to $24.00 and gave the company an "overweight" rating in a research note on Thursday, January 21st. Deutsche Bank Aktiengesellschaft raised shares of Medical Properties Trust from a "hold" rating to a "buy" rating and set a $24.00 target price for the company in a research note on Tuesday, December 15th. Truist cut shares of Medical Properties Trust from a "buy" rating to a "hold" rating and raised their target price for the company from $21.00 to $22.00 in a research note on Friday, January 22nd. Barclays raised their target price on shares of Medical Properties Trust from $23.00 to $25.00 and gave the company an "overweight" rating in a research note on Monday, February 8th. Finally, TheStreet cut shares of Medical Properties Trust from a "b" rating to a "c+" rating in a research note on Thursday, February 4th. Two research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Medical Properties Trust has an average rating of "Buy" and an average price target of $22.89.

Shares of MPW opened at $21.80 on Thursday. The stock has a market capitalization of $12.64 billion, a P/E ratio of 25.06, a P/E/G ratio of 1.39 and a beta of 0.56. Medical Properties Trust has a twelve month low of $15.30 and a twelve month high of $22.75. The company has a 50 day moving average of $21.55 and a 200-day moving average of $20.35. The company has a quick ratio of 3.54, a current ratio of 3.54 and a debt-to-equity ratio of 1.14.

Medical Properties Trust (NYSE:MPW) last issued its quarterly earnings results on Thursday, February 4th. The real estate investment trust reported $0.20 earnings per share for the quarter, missing the consensus estimate of $0.41 by ($0.21). The business had revenue of $333.80 million for the quarter, compared to the consensus estimate of $332.44 million. Medical Properties Trust had a return on equity of 6.60% and a net margin of 38.50%. Medical Properties Trust's revenue was up 30.2% compared to the same quarter last year. During the same period in the prior year, the business earned $0.35 earnings per share. On average, sell-side analysts anticipate that Medical Properties Trust will post 1.57 earnings per share for the current fiscal year.

In other Medical Properties Trust news, CEO Edward K. Aldag, Jr. sold 710,000 shares of Medical Properties Trust stock in a transaction dated Tuesday, March 30th. The stock was sold at an average price of $21.21, for a total value of $15,059,100.00. Following the transaction, the chief executive officer now owns 3,251,167 shares in the company, valued at $68,957,252.07. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO R Steven Hamner sold 250,000 shares of Medical Properties Trust stock in a transaction dated Wednesday, February 24th. The shares were sold at an average price of $22.49, for a total value of $5,622,500.00. Following the completion of the transaction, the chief financial officer now owns 1,792,688 shares in the company, valued at approximately $40,317,553.12. The disclosure for this sale can be found here. In the last ninety days, insiders sold 993,000 shares of company stock valued at $21,385,160. 1.18% of the stock is owned by insiders.

Institutional investors have recently added to or reduced their stakes in the business. Griffin Asset Management Inc. bought a new stake in shares of Medical Properties Trust during the fourth quarter worth about $340,000. SG Americas Securities LLC lifted its stake in shares of Medical Properties Trust by 915.6% in the fourth quarter. SG Americas Securities LLC now owns 242,370 shares of the real estate investment trust's stock worth $5,281,000 after acquiring an additional 218,506 shares during the period. Paloma Partners Management Co lifted its stake in shares of Medical Properties Trust by 85.4% in the third quarter. Paloma Partners Management Co now owns 78,841 shares of the real estate investment trust's stock worth $1,390,000 after acquiring an additional 36,315 shares during the period. Cubist Systematic Strategies LLC lifted its stake in shares of Medical Properties Trust by 306.9% in the third quarter. Cubist Systematic Strategies LLC now owns 477,543 shares of the real estate investment trust's stock worth $8,419,000 after acquiring an additional 360,168 shares during the period. Finally, Pendal Group Limited acquired a new position in shares of Medical Properties Trust in the fourth quarter worth approximately $287,000. Hedge funds and other institutional investors own 80.17% of the company's stock.

About Medical Properties Trust

Medical Properties Trust, Inc is a self-advised real estate investment trust, which engages in the investment, acquisition, and development of net-leased healthcare facilities. Its property portfolio includes rehabilitation hospitals; long-term acute care hospitals; ambulatory surgery centers; hospitals for women and children; regional and community hospitals; medical office buildings; and other single-discipline facilities.

Read More: How to Trade Using Analysts Ratings

Get a free copy of the Zacks research report on Medical Properties Trust (MPW)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Medical Properties Trust (NYSE:MPW)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Featured Article: How to Use the MarketBeat Retirement Calculator



7 Outdoor Recreation Stocks For Growth And Dividends

If American’s liked outdoor activities before, they love them even more now. The COVID-19 pandemic has done many things, and one of them is reinvigorating American’s love of the outdoors. Data from across the industry shows a sustained uptick in revenue that has the entire complex moving higher.

The RV Industry Association, for example, reports shipments of RVs are up greater than 30% in 2020 and are expected to grow another 20% or more in 2021. If data from the two of the industry’s largest manufacturers are any indication, that forecast is very conservative.

And the gains aren’t limited to RVs. Everything that has anything to do with outdoor recreation is booming. Sales at Dicks Sporting Goods, an iconic brand for retail and the outdoors, has seen a sustained 20% increase in revenue since the 2nd quarter shutdowns. If anything, revenue in this sector is being held back by rapidly declining inventory and tight shipping conditions.

The stocks we are about to show all have something in common; the outdoors. Within the group, you will find everything from RVs to Radios and everything in between an outdoor enthusiast could need or want. Some pay dividends and some don’t, but all will deliver solid returns to investors in 2021.

View the "7 Outdoor Recreation Stocks For Growth And Dividends".


MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.